We have reviewed all known UK cases of Smith-Lemli-Opitz syndrome. Among 49 cases with proven 7-dehydrocholesterol reductase deficiency, half had been terminated or had died in infancy. The minimum incidence is 1 in 60 000. The frequent occurrence of hypospadias may account for 71% of recognised cases being male. Important common features which emerged include short thumbs, severe photosensitivity, aggressive behaviour, and atrioventricular septal defect. The typical facial appearance becomes less obvious with age and 20% of cases did not have 2/3 toe syndactyly. Biochemical measurements of serum 7-dehydrocholesterol did not correlate with clinical severity.
Smith-Lemli-Opitz (SLO) syndrome is an autosomal recessive mental retardation/ multiple congenital anomaly syndrome first described by Smith et al' in 1964. The incidence is estimated to be 1 in 20 000 to 1 in 50 000 with a carrier frequency of 0.014.2 3 Before 1993, diagnosis was based on characteristic clinical features, including mental retardation, failure to thrive, dysmorphic facies, cleft palate, congenital heart disease, hypospadias, and 2/3 toe syndactyly. There is a wide clinical spectrum, ranging from mild developmental delay and syndactyly to lethal multiorgan anomalies. 2 4 In 1993 and 1994, Irons et ar and Tint et alt showed that very low levels of cholesterol and markedly raised levels of the cholesterol precursor 7-dehydrocholesterol (7DHC) were present in subjects with both the severe and the milder forms of SLO. In 1995, Honda et af showed that SLO resulted from a primary defect in the enzyme 7-dehydrocholesterol reductase, which normally converts 7DHC to cholesterol. Hypocholesterolaemia and raised 7DHC are present in blood and other tissues. Cholesterol is vital for the normal structure of cell and mitochondrial membranes, development of the central nervous system, and myelination, and for normal synthesis and metabolism of steroids, bile acids, and vitamin D. It is postulated that the excess of 7DHC or deficiency of cholesterol or It has been suggested that dietary intervention at an early age may improve the neurological and physical outcome in these children. 4 12 Trials of high dose cholesterol and bile acid supplementation have been introduced to a small number of patients and preliminary reports suggest that the children are better behaved and there are some reports of acceleration of neurological progress. Conclusions on the value of therapy are dependent upon a clear delineation of the natural history of the disease.
With the advent of a biochemical marker for diagnosis, the "well defined clinical spectrum", born of "minimal diagnostic criteria",13 has become amenable to independent evaluation. We have reviewed all known SLO patients in the UK in order to establish the clinical spectrum. 14 29 13t, 40 §, 47t
Subjects and methods
Lung anomaly 12 24 33 §, 56: Gastrointestinal abnormality 15 
Results
In some instances, data were not available or were not applicable, for example, the presence of ptosis cannot be determined in fetuses and feeding data were not available in those infants who died in the early neonatal period. We have given numbers of patients with each abnormality for each section, and where the denominator is not the total 49 patients, this is specified. The main clinical features are summarised in table 1.
INCIDENCE
Fifteen subjects (10 male, five female) were known to have been born or terminated in the UK in 1995 and 1996. The male birth rate in the UK is approximately 300 000 births per year. Therefore, the minimum incidence is 1/60 000 males per year and the minimum birth prevalence is 1/67 000 males per year. Assuming females and males are affected in equal numbers (but that more males are diagnosed because of the presence of genital abnormalities), this is equivalent to a minimum carrier frequency of 1 in 122 (0.8%). The parents of one child were distantly related. probands), 16 miscarriages, and seven terminated fetuses. Subsequent to the probands' births, there were nine affected SLO cases from 28 conceptions (28%); six were liveborn and three were terminated. Three of these subsequently affected cases (one liveborn, two terminated fetuses) were not included in the study because of insufficient clinical detail.
For 44 pregnancies, a maternal obstetric history was available. Of these, 16 within the first year. The oldest death was at 14 years. Death was the result of congenital heart disease or multiple congenital abnormalities including lung and renal hypoplasia in the majority of cases. Twenty-four patients were alive, with ages ranging between 4 months and 38 years at the time of examination; the majority were aged less than 12 years. There were five adults, aged 22 to 38 years.
The majority of patients were diagnosed as having SLO at necropsy or within the first month of life. All subjects were scored to rate their severity of congenital anomalies (range 2-15, mean=6.51, SD 2.84) (fig 1) . The majority of patients had one or more major structural congenital abnormality in addition to facial dysmorphism and developmental delay. There were 11 patients without major organ malformations but with one or more minor malformations. For example, one male patient had bilateral 2/3 toe syndactyly, right talipes equinovalgus, mild dysmorphic features, mild learning difficulties, feeding difficulties, and ptosis (fig 2A) . Another male infant had congenital dislocation of the hip, bifid uvula, right undescended testis, and facial dysmorphism. One female had mild developmental delay, bilateral 2/3 toe syndactyly, short thumbs, mild dysmorphic features, and failure to thrive, but did not require nasogastric tube feeding ( fig 2B) .
Assessment of severity of mental retardation in those patients living at least six months (25 patients) was based upon developmental milestones, medical records, school performance reports, formal developmental assessment, and physical examination. Two were in the normal range, although they were aged only 8 months and 10 months at the time of assessment. Twenty-three of 25 (92%) had mental retardation; four (16%) had mild, seven (28%) had moderate, and 12 (48%) had severe mental retardation.
There were 11 sibs from five families. Three sets of sibs are alive and two sibships of two and three sibs (two sibs and one terminated fetus) all died within the first month of life. The phenotype was broadly concordant within sibships; their severity scores were (3, 5) , (9,9), (5,7), (8, 6, 8) , and (6,3).
The majority of patients had severe feeding difficulties in infancy with poor suck, lack of interest in feeds, and vomiting. All but six patients required nasogastric tube feeding for between 4 months and 8 years. The vomiting and feeding difficulties tended to improve as the children grew older, though gastrostomy/ fundoplication was required in eight patients. Medical treatment for gastro-oesophageal reflux was generally ineffective.
PHYSICAL FINDINGS Growth Growth data were available for all 24 living patients. Average birth weight was 2700 g at 38 weeks' gestation. Failure to thrive was seen in 21/24 (88%), who were below the 3rd centile for height/weight parameters. The majority were born with heights and weights within the normal range but gradually fell across and then 
